FY08annualreportrevised.indd

First Page		Document Content
Date: 2012-05-11 07:27:17 Tumor suppressor genes Von Hippel–Lindau tumor suppressor Von Hippel–Lindau disease Kidney cancer Hemangioblastoma Hypoxia-inducible factors Vascular endothelial growth factor Angiogenesis Bevacizumab Medicine Oncology Angiology		FY08annualreportrevised.indd Add to Reading List Source URL: vhl.org Download Document from Source Website File Size: 295,10 KB Share Document on Facebook

	1 VON HIPPEL-LINDAU DISEASE: A Model Project Prevention and preventive intervention in a hereditary tumor syndrome By Hartmut P.H. Neumann, M.D., University Medical Center, Freiburg, Germany DocID: 1u751 - View Document
	The Road to Diagnosis: Stories from Patients with Rare Diseases Personal stories from members of Inspire’s online support communities A Special Report from Inspire in recognition of Rare Disease Day 2011 DocID: 197Fz - View Document
	MADRID PRESENTATION SUMMARIES Selected lectures and illustrations TABLE OF CONTENTS Basic and clinical research in pheochromocytoma…………………………………………………………………..………… DocID: 11t1Z - View Document
	Citation: Cell Death and Disease[removed], e164; doi:[removed]cddis[removed] & 2011 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Review DocID: ZLKb - View Document
	Citation: Cell Death and Disease[removed], e305; doi:[removed]cddis[removed] & 2012 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis The double life of MULE in preeclamptic and DocID: Ztcz - View Document